Go Pro

Cigna Group $CI Stock Position Trimmed by Fifth Third Bancorp

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Fifth Third Bancorp reduced its Cigna position by 5.5% in the second quarter, selling 4,197 shares and retaining 72,463 shares valued at approximately $20.0 million. Institutional investors collectively own 86.99% of Cigna’s stock.
  • Cigna reported quarterly adjusted earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company maintained fiscal 2026 earnings guidance near $30.45 per share.
  • Analysts remain generally positive, with 15 Buy ratings and 7 Holds and a consensus price target of $339.45 versus the stock’s $282.24 opening price. Cigna also declared a quarterly dividend of $1.56 per share, yielding approximately 2.2% annually.
  • Five stocks to consider instead of Cigna Group.

Fifth Third Bancorp trimmed its position in shares of Cigna Group (NYSE:CI - Free Report) by 5.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 72,463 shares of the health services provider's stock after selling 4,197 shares during the period. Fifth Third Bancorp's holdings in Cigna Group were worth $19,977,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group in the 4th quarter valued at approximately $25,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group during the 4th quarter worth $29,000. Prosperity Bancshares Inc acquired a new position in Cigna Group during the 4th quarter worth $29,000. Cedar Mountain Advisors LLC grew its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV grew its stake in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider's stock worth $37,000 after purchasing an additional 81 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Cantor Fitzgerald lifted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research note on Friday, May 1st. UBS Group increased their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, May 22nd. Barclays raised their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. Wall Street Zen downgraded shares of Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. Finally, Robert W. Baird set a $362.00 price target on shares of Cigna Group in a research note on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Cigna Group currently has an average rating of "Moderate Buy" and a consensus price target of $339.45.

Read Our Latest Stock Report on CI

Cigna Group Trading Up 1.5%

Shares of Cigna Group stock opened at $282.24 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. The business has a fifty day simple moving average of $286.02 and a 200-day simple moving average of $281.28. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. During the same quarter last year, the business posted $7.20 earnings per share. The company's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is 25.82%.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company's stock.

Cigna Group Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines